Subclinical atrial fibrillation and the risk of stroke.

By J. Healey, S. Connolly, M. Gold, C. Israel, I. C. Gelder, A. Capucci, C. Lau, E. Fain, Sean Yang, C. Bailleul and 5 more. New England Journal of Medicine, 2012

1,858 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/510d707a163ff299da03280772a4b0dfaef1eef4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Gerhard Hindricks
2. Gregory Y. H. Lip
3. Stanley Nattel
4. Cynthia Rudin

Citations in the corpus

• Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report (2012, background): “1515 1516 Patient self-monitoring and self-management 1517 A recent Cochrane review 91 evaluating the effect of self-monitoring or self-management of OAC 1518 therapy compared to standard OAC monitoring on thromboembolic events, major bleeding and 1519 death revealed a significant decrease in thromb”
• Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events (2014, methodology): “Although ASSERT demonstrated an association between SCAF and embolic events,(8) ASSERT does not provide any evidence that oral anticoagulation will have the same effectiveness in this population as it does for patients with clinical AF, and therefore many investigators are suggesting that randomized”